Avail upto 30% off on all reports till July 31st.

Covid-19 Impact on Global CRISPR Genome Editing Market Size, Status and Forecast 2020-2026

Date: Jun 29 2020
|
QYRESEARCH
|
Number of Pages: 127
|
Category: Medical Care

This report focuses on the global CRISPR Genome Editing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRISPR Genome Editing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics

Market segment by Type, the product can be split into
Genetic Engineering
Gene Library
Human Stem Cells
Others
Market segment by Application, split into
Biotechnology Companies
Pharmaceutical Companies
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CRISPR Genome Editing status, future forecast, growth opportunity, key market and key players.
To present the CRISPR Genome Editing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of CRISPR Genome Editing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered: Ranking by CRISPR Genome Editing Revenue
    1.4 Market Analysis by Type
           1.4.1 Global CRISPR Genome Editing Market Size Growth Rate by Type: 2020 VS 2026
           1.4.2 Genetic Engineering
           1.4.3 Gene Library
           1.4.4 Human Stem Cells
           1.4.5 Others
    1.5 Market by Application
           1.5.1 Global CRISPR Genome Editing Market Share by Application: 2020 VS 2026
           1.5.2 Biotechnology Companies
           1.5.3 Pharmaceutical Companies
           1.5.4 Others
    1.6 Coronavirus Disease 2019 (Covid-19): CRISPR Genome Editing Industry Impact
           1.6.1 How the Covid-19 is Affecting the CRISPR Genome Editing Industry
                 1.6.1.1 CRISPR Genome Editing Business Impact Assessment - Covid-19
                 1.6.1.2 Supply Chain Challenges
                 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
           1.6.2 Market Trends and CRISPR Genome Editing Potential Opportunities in the COVID-19 Landscape
           1.6.3 Measures / Proposal against Covid-19
                 1.6.3.1 Government Measures to Combat Covid-19 Impact
                 1.6.3.2 Proposal for CRISPR Genome Editing Players to Combat Covid-19 Impact
    1.7 Study Objectives
    1.8 Years Considered
2 Global Growth Trends by Regions
    2.1 CRISPR Genome Editing Market Perspective (2015-2026)
    2.2 CRISPR Genome Editing Growth Trends by Regions
           2.2.1 CRISPR Genome Editing Market Size by Regions: 2015 VS 2020 VS 2026
           2.2.2 CRISPR Genome Editing Historic Market Share by Regions (2015-2020)
           2.2.3 CRISPR Genome Editing Forecasted Market Size by Regions (2021-2026)
    2.3 Industry Trends and Growth Strategy
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Challenges
           2.3.4 Porter’s Five Forces Analysis
           2.3.5 CRISPR Genome Editing Market Growth Strategy
           2.3.6 Primary Interviews with Key CRISPR Genome Editing Players (Opinion Leaders)
3 Competition Landscape by Key Players
    3.1 Global Top CRISPR Genome Editing Players by Market Size
           3.1.1 Global Top CRISPR Genome Editing Players by Revenue (2015-2020)
           3.1.2 Global CRISPR Genome Editing Revenue Market Share by Players (2015-2020)
           3.1.3 Global CRISPR Genome Editing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.2 Global CRISPR Genome Editing Market Concentration Ratio
           3.2.1 Global CRISPR Genome Editing Market Concentration Ratio (CR5 and HHI)
           3.2.2 Global Top 10 and Top 5 Companies by CRISPR Genome Editing Revenue in 2019
    3.3 CRISPR Genome Editing Key Players Head office and Area Served
    3.4 Key Players CRISPR Genome Editing Product Solution and Service
    3.5 Date of Enter into CRISPR Genome Editing Market
    3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
    4.1 Global CRISPR Genome Editing Historic Market Size by Type (2015-2020)
    4.2 Global CRISPR Genome Editing Forecasted Market Size by Type (2021-2026)
5 CRISPR Genome Editing Breakdown Data by Application (2015-2026)
    5.1 Global CRISPR Genome Editing Market Size by Application (2015-2020)
    5.2 Global CRISPR Genome Editing Forecasted Market Size by Application (2021-2026)
6 North America
    6.1 North America CRISPR Genome Editing Market Size (2015-2020)
    6.2 CRISPR Genome Editing Key Players in North America (2019-2020)
    6.3 North America CRISPR Genome Editing Market Size by Type (2015-2020)
    6.4 North America CRISPR Genome Editing Market Size by Application (2015-2020)
7 Europe
    7.1 Europe CRISPR Genome Editing Market Size (2015-2020)
    7.2 CRISPR Genome Editing Key Players in Europe (2019-2020)
    7.3 Europe CRISPR Genome Editing Market Size by Type (2015-2020)
    7.4 Europe CRISPR Genome Editing Market Size by Application (2015-2020)
8 China
    8.1 China CRISPR Genome Editing Market Size (2015-2020)
    8.2 CRISPR Genome Editing Key Players in China (2019-2020)
    8.3 China CRISPR Genome Editing Market Size by Type (2015-2020)
    8.4 China CRISPR Genome Editing Market Size by Application (2015-2020)
9 Japan
    9.1 Japan CRISPR Genome Editing Market Size (2015-2020)
    9.2 CRISPR Genome Editing Key Players in Japan (2019-2020)
    9.3 Japan CRISPR Genome Editing Market Size by Type (2015-2020)
    9.4 Japan CRISPR Genome Editing Market Size by Application (2015-2020)
10 Southeast Asia
    10.1 Southeast Asia CRISPR Genome Editing Market Size (2015-2020)
    10.2 CRISPR Genome Editing Key Players in Southeast Asia (2019-2020)
    10.3 Southeast Asia CRISPR Genome Editing Market Size by Type (2015-2020)
    10.4 Southeast Asia CRISPR Genome Editing Market Size by Application (2015-2020)
11 India
    11.1 India CRISPR Genome Editing Market Size (2015-2020)
    11.2 CRISPR Genome Editing Key Players in India (2019-2020)
    11.3 India CRISPR Genome Editing Market Size by Type (2015-2020)
    11.4 India CRISPR Genome Editing Market Size by Application (2015-2020)
12 Central & South America
    12.1 Central & South America CRISPR Genome Editing Market Size (2015-2020)
    12.2 CRISPR Genome Editing Key Players in Central & South America (2019-2020)
    12.3 Central & South America CRISPR Genome Editing Market Size by Type (2015-2020)
    12.4 Central & South America CRISPR Genome Editing Market Size by Application (2015-2020)
13 Key Players Profiles
    13.1 Editas Medicine
           13.1.1 Editas Medicine Company Details
           13.1.2 Editas Medicine Business Overview and Its Total Revenue
           13.1.3 Editas Medicine CRISPR Genome Editing Introduction
           13.1.4 Editas Medicine Revenue in CRISPR Genome Editing Business (2015-2020))
           13.1.5 Editas Medicine Recent Development
    13.2 CRISPR Therapeutics
           13.2.1 CRISPR Therapeutics Company Details
           13.2.2 CRISPR Therapeutics Business Overview and Its Total Revenue
           13.2.3 CRISPR Therapeutics CRISPR Genome Editing Introduction
           13.2.4 CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020)
           13.2.5 CRISPR Therapeutics Recent Development
    13.3 Horizon Discovery
           13.3.1 Horizon Discovery Company Details
           13.3.2 Horizon Discovery Business Overview and Its Total Revenue
           13.3.3 Horizon Discovery CRISPR Genome Editing Introduction
           13.3.4 Horizon Discovery Revenue in CRISPR Genome Editing Business (2015-2020)
           13.3.5 Horizon Discovery Recent Development
    13.4 Sigma-Aldrich
           13.4.1 Sigma-Aldrich Company Details
           13.4.2 Sigma-Aldrich Business Overview and Its Total Revenue
           13.4.3 Sigma-Aldrich CRISPR Genome Editing Introduction
           13.4.4 Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2015-2020)
           13.4.5 Sigma-Aldrich Recent Development
    13.5 Genscript
           13.5.1 Genscript Company Details
           13.5.2 Genscript Business Overview and Its Total Revenue
           13.5.3 Genscript CRISPR Genome Editing Introduction
           13.5.4 Genscript Revenue in CRISPR Genome Editing Business (2015-2020)
           13.5.5 Genscript Recent Development
    13.6 Sangamo Biosciences
           13.6.1 Sangamo Biosciences Company Details
           13.6.2 Sangamo Biosciences Business Overview and Its Total Revenue
           13.6.3 Sangamo Biosciences CRISPR Genome Editing Introduction
           13.6.4 Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
           13.6.5 Sangamo Biosciences Recent Development
    13.7 Lonza Group
           13.7.1 Lonza Group Company Details
           13.7.2 Lonza Group Business Overview and Its Total Revenue
           13.7.3 Lonza Group CRISPR Genome Editing Introduction
           13.7.4 Lonza Group Revenue in CRISPR Genome Editing Business (2015-2020)
           13.7.5 Lonza Group Recent Development
    13.8 Integrated DNA Technologies
           13.8.1 Integrated DNA Technologies Company Details
           13.8.2 Integrated DNA Technologies Business Overview and Its Total Revenue
           13.8.3 Integrated DNA Technologies CRISPR Genome Editing Introduction
           13.8.4 Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2015-2020)
           13.8.5 Integrated DNA Technologies Recent Development
    13.9 New England Biolabs
           13.9.1 New England Biolabs Company Details
           13.9.2 New England Biolabs Business Overview and Its Total Revenue
           13.9.3 New England Biolabs CRISPR Genome Editing Introduction
           13.9.4 New England Biolabs Revenue in CRISPR Genome Editing Business (2015-2020)
           13.9.5 New England Biolabs Recent Development
    13.10 Origene Technologies
           13.10.1 Origene Technologies Company Details
           13.10.2 Origene Technologies Business Overview and Its Total Revenue
           13.10.3 Origene Technologies CRISPR Genome Editing Introduction
           13.10.4 Origene Technologies Revenue in CRISPR Genome Editing Business (2015-2020)
           13.10.5 Origene Technologies Recent Development
    13.11 Transposagen Biopharmaceuticals
           10.11.1 Transposagen Biopharmaceuticals Company Details
           10.11.2 Transposagen Biopharmaceuticals Business Overview and Its Total Revenue
           10.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Introduction
           10.11.4 Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2015-2020)
           10.11.5 Transposagen Biopharmaceuticals Recent Development
    13.12 Thermo Fisher Scientific
           10.12.1 Thermo Fisher Scientific Company Details
           10.12.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
           10.12.3 Thermo Fisher Scientific CRISPR Genome Editing Introduction
           10.12.4 Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2015-2020)
           10.12.5 Thermo Fisher Scientific Recent Development
    13.13 Caribou Biosciences
           10.13.1 Caribou Biosciences Company Details
           10.13.2 Caribou Biosciences Business Overview and Its Total Revenue
           10.13.3 Caribou Biosciences CRISPR Genome Editing Introduction
           10.13.4 Caribou Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
           10.13.5 Caribou Biosciences Recent Development
    13.14 Precision Biosciences
           10.14.1 Precision Biosciences Company Details
           10.14.2 Precision Biosciences Business Overview and Its Total Revenue
           10.14.3 Precision Biosciences CRISPR Genome Editing Introduction
           10.14.4 Precision Biosciences Revenue in CRISPR Genome Editing Business (2015-2020)
           10.14.5 Precision Biosciences Recent Development
    13.15 Cellectis
           10.15.1 Cellectis Company Details
           10.15.2 Cellectis Business Overview and Its Total Revenue
           10.15.3 Cellectis CRISPR Genome Editing Introduction
           10.15.4 Cellectis Revenue in CRISPR Genome Editing Business (2015-2020)
           10.15.5 Cellectis Recent Development
    13.16 Intellia Therapeutics
           10.16.1 Intellia Therapeutics Company Details
           10.16.2 Intellia Therapeutics Business Overview and Its Total Revenue
           10.16.3 Intellia Therapeutics CRISPR Genome Editing Introduction
           10.16.4 Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020)
           10.16.5 Intellia Therapeutics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
           15.1.2 Data Source
    15.2 Disclaimer
    15.3 Author Details

List of Tables
Table 1. CRISPR Genome Editing Key Market Segments
Table 2. Key Players Covered: Ranking by CRISPR Genome Editing Revenue
Table 3. Ranking of Global Top CRISPR Genome Editing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CRISPR Genome Editing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Genetic Engineering
Table 6. Key Players of Gene Library
Table 7. Key Players of Human Stem Cells
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four CRISPR Genome Editing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for CRISPR Genome Editing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for CRISPR Genome Editing Players to Combat Covid-19 Impact
Table 14. Global CRISPR Genome Editing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global CRISPR Genome Editing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global CRISPR Genome Editing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global CRISPR Genome Editing Market Share by Regions (2015-2020)
Table 18. Global CRISPR Genome Editing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global CRISPR Genome Editing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. CRISPR Genome Editing Market Growth Strategy
Table 24. Main Points Interviewed from Key CRISPR Genome Editing Players
Table 25. Global CRISPR Genome Editing Revenue by Players (2015-2020) (Million US$)
Table 26. Global CRISPR Genome Editing Market Share by Players (2015-2020)
Table 27. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2019)
Table 28. Global CRISPR Genome Editing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players CRISPR Genome Editing Product Solution and Service
Table 31. Date of Enter into CRISPR Genome Editing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 34. Global CRISPR Genome Editing Market Size Share by Type (2015-2020)
Table 35. Global CRISPR Genome Editing Revenue Market Share by Type (2021-2026)
Table 36. Global CRISPR Genome Editing Market Size Share by Application (2015-2020)
Table 37. Global CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 38. Global CRISPR Genome Editing Market Size Share by Application (2021-2026)
Table 39. North America Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 41. North America CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 42. North America CRISPR Genome Editing Market Share by Type (2015-2020)
Table 43. North America CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 44. North America CRISPR Genome Editing Market Share by Application (2015-2020)
Table 45. Europe Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 47. Europe CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe CRISPR Genome Editing Market Share by Type (2015-2020)
Table 49. Europe CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe CRISPR Genome Editing Market Share by Application (2015-2020)
Table 51. China Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 52. China Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 53. China CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 54. China CRISPR Genome Editing Market Share by Type (2015-2020)
Table 55. China CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 56. China CRISPR Genome Editing Market Share by Application (2015-2020)
Table 57. Japan Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 59. Japan CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan CRISPR Genome Editing Market Share by Type (2015-2020)
Table 61. Japan CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan CRISPR Genome Editing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 65. Southeast Asia CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia CRISPR Genome Editing Market Share by Type (2015-2020)
Table 67. Southeast Asia CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia CRISPR Genome Editing Market Share by Application (2015-2020)
Table 69. India Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 70. India Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 71. India CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 72. India CRISPR Genome Editing Market Share by Type (2015-2020)
Table 73. India CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 74. India CRISPR Genome Editing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players CRISPR Genome Editing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players CRISPR Genome Editing Market Share (2019-2020)
Table 77. Central & South America CRISPR Genome Editing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America CRISPR Genome Editing Market Share by Type (2015-2020)
Table 79. Central & South America CRISPR Genome Editing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America CRISPR Genome Editing Market Share by Application (2015-2020)
Table 81. Editas Medicine Company Details
Table 82. Editas Medicine Business Overview
Table 83. Editas Medicine Product
Table 84. Editas Medicine Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 85. Editas Medicine Recent Development
Table 86. CRISPR Therapeutics Company Details
Table 87. CRISPR Therapeutics Business Overview
Table 88. CRISPR Therapeutics Product
Table 89. CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 90. CRISPR Therapeutics Recent Development
Table 91. Horizon Discovery Company Details
Table 92. Horizon Discovery Business Overview
Table 93. Horizon Discovery Product
Table 94. Horizon Discovery Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 95. Horizon Discovery Recent Development
Table 96. Sigma-Aldrich Company Details
Table 97. Sigma-Aldrich Business Overview
Table 98. Sigma-Aldrich Product
Table 99. Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 100. Sigma-Aldrich Recent Development
Table 101. Genscript Company Details
Table 102. Genscript Business Overview
Table 103. Genscript Product
Table 104. Genscript Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 105. Genscript Recent Development
Table 106. Sangamo Biosciences Company Details
Table 107. Sangamo Biosciences Business Overview
Table 108. Sangamo Biosciences Product
Table 109. Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 110. Sangamo Biosciences Recent Development
Table 111. Lonza Group Company Details
Table 112. Lonza Group Business Overview
Table 113. Lonza Group Product
Table 114. Lonza Group Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 115. Lonza Group Recent Development
Table 116. Integrated DNA Technologies Business Overview
Table 117. Integrated DNA Technologies Product
Table 118. Integrated DNA Technologies Company Details
Table 119. Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 120. Integrated DNA Technologies Recent Development
Table 121. New England Biolabs Company Details
Table 122. New England Biolabs Business Overview
Table 123. New England Biolabs Product
Table 124. New England Biolabs Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 125. New England Biolabs Recent Development
Table 126. Origene Technologies Company Details
Table 127. Origene Technologies Business Overview
Table 128. Origene Technologies Product
Table 129. Origene Technologies Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 130. Origene Technologies Recent Development
Table 131. Transposagen Biopharmaceuticals Company Details
Table 132. Transposagen Biopharmaceuticals Business Overview
Table 133. Transposagen Biopharmaceuticals Product
Table 134. Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 135. Transposagen Biopharmaceuticals Recent Development
Table 136. Thermo Fisher Scientific Company Details
Table 137. Thermo Fisher Scientific Business Overview
Table 138. Thermo Fisher Scientific Product
Table 139. Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 140. Thermo Fisher Scientific Recent Development
Table 141. Caribou Biosciences Company Details
Table 142. Caribou Biosciences Business Overview
Table 143. Caribou Biosciences Product
Table 144. Caribou Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 145. Caribou Biosciences Recent Development
Table 146. Precision Biosciences Company Details
Table 147. Precision Biosciences Business Overview
Table 148. Precision Biosciences Product
Table 149. Precision Biosciences Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 150. Precision Biosciences Recent Development
Table 151. Cellectis Company Details
Table 152. Cellectis Business Overview
Table 153. Cellectis Product
Table 154. Cellectis Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 155. Cellectis Recent Development
Table 156. Intellia Therapeutics Company Details
Table 157. Intellia Therapeutics Business Overview
Table 158. Intellia Therapeutics Product
Table 159. Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2015-2020) (Million US$)
Table 160. Intellia Therapeutics Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR Genome Editing Market Share by Type: 2020 VS 2026
Figure 2. Genetic Engineering Features
Figure 3. Gene Library Features
Figure 4. Human Stem Cells Features
Figure 5. Others Features
Figure 6. Global CRISPR Genome Editing Market Share by Application: 2020 VS 2026
Figure 7. Biotechnology Companies Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Others Case Studies
Figure 10. CRISPR Genome Editing Report Years Considered
Figure 11. Global CRISPR Genome Editing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global CRISPR Genome Editing Market Share by Regions: 2020 VS 2026
Figure 13. Global CRISPR Genome Editing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global CRISPR Genome Editing Market Share by Players in 2019
Figure 16. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by CRISPR Genome Editing Revenue in 2019
Figure 18. North America CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America CRISPR Genome Editing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Editas Medicine Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 27. CRISPR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CRISPR Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 29. Horizon Discovery Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Horizon Discovery Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 31. Sigma-Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sigma-Aldrich Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 33. Genscript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Genscript Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 35. Sangamo Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sangamo Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 37. Lonza Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Lonza Group Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 39. Integrated DNA Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Integrated DNA Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 41. New England Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. New England Biolabs Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 43. Origene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Origene Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 45. Transposagen Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Transposagen Biopharmaceuticals Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 47. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 49. Caribou Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Caribou Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 51. Precision Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Precision Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 53. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cellectis Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 55. Intellia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Intellia Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Electronic files(PDF) of market research reports will be dispatched within 48-72 hours. (Mon-Fri IST)

Select License Type

Why Choose InForGrowth?
  • Customer Insights
  • Market Opportunity Mapping
  • Competitive Intelligence for Key Companies
  • Market Entry Strategy
  • Product Mix and Pricing
  • Segmentation Analysis
  • Benchmarking Research based on Ecosystem and Interconnectivity
  • Market Attractiveness Framework
  • Demand-Supply Scenario & Performance Optimization
  • Technology Landscape & Revenue Augmenting Plans
  • Impact of Circular Economy or Digital Transformation Trends
  • Region Specific Reports / Country Specific Reports for Specific Topics
  • As Per Customer Need Section Wise Reports
  • Subscription Service with Real-Time Updates
  • Access to all the Research Studies in the Chosen Domains/Verticals
  • Pre and Post-Sales Service and Support
Need Help?
+
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.